UroMems Gains FDA and ANSM Approval for Breakthrough Clinical Study of UroActive Implant for Male Incontinence UroMems has received FDA and ANSM approval to initiate a clinical study for UroActive, an innovative implant aimed at treating male stress urinary incontinence, marking a significant step in medical technology.

UroMems Gains FDA and ANSM Approval for Breakthrough Clinical Study of UroActive Implant for Male Incontinence #USA #Minneapolis #UroMems #UroActive #Stress_Incontinence

UroMems Breakthrough Study Reveals Promising Results for Female Stress Urinary Incontinence Treatment UroMems announces groundbreaking results from the first-ever female clinical study of UroActive® smart implant, demonstrating promising feasibility and transforming treatment options for stress urinary incontinence.

UroMems Breakthrough Study Reveals Promising Results for Female Stress Urinary Incontinence Treatment #France #UroMems #Grenoble #UroActive #Stress_Incontinence